piperaquinoline Report issue

Small molecule Experimental
AACT ChEMBL Drug Central MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

Alternative names

1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane | 1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine) | piperaquine | piperaquine phosphate | piperaquine tetraphosphate | piperaquinoline | quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)

Organizations (148)

Research & Development (148)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (25)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (25)


 

Anemia (Phase 4)

Cardiotoxicity (Phase 2)

Drug Combinations (Phase 1)

Drugs, Investigational (Phase 3)

Fever (Phase 3)

Glucosephosphate Dehydrogenase Deficiency (Phase 4)

Healthy Volunteers (Phase 4)

HIV (Phase 3)

HIV Infections (Phase 3)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Malaria Vaccines (Phase 2)

Malaria, Vivax (Phase 4)

Neoplasm Metastasis (Phase 3)

Parasitemia (Phase 2)

Parasitic Diseases (Phase 4)

Pharmacokinetics (Phase 4)

Pharmacological and Toxicological Phenomena (Phase 2)

Plasmodium (Phase 4)

Plasmodium falciparum (Phase 4)

Plasmodium vivax (Phase 1/Phase 2)

Pregnancy (Phase 4)

Pregnancy Complications (Phase 3)

Stomach Neoplasms (Phase 3)

Treatment Outcome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 102
  • # of Trial Organizations: 148

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue